| __timestamp | Pharming Group N.V. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4167274 | 5758000 |
| Thursday, January 1, 2015 | 5247851 | 8423000 |
| Friday, January 1, 2016 | 4925118 | 11986000 |
| Sunday, January 1, 2017 | 14930297 | 15215000 |
| Monday, January 1, 2018 | 25371768 | 15356000 |
| Tuesday, January 1, 2019 | 23921274 | 16660000 |
| Wednesday, January 1, 2020 | 25338236 | 52459000 |
| Friday, January 1, 2021 | 20182966 | 75061000 |
| Saturday, January 1, 2022 | 17562000 | 87221000 |
| Sunday, January 1, 2023 | 25212000 | 83779000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for strategic planning and competitive advantage. This analysis delves into the cost of revenue trends for Pharming Group N.V. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Pharming Group N.V. saw a steady increase in costs, peaking in 2018 with a 510% rise from 2014. Meanwhile, Supernus Pharmaceuticals, Inc. experienced a dramatic surge, with costs escalating by over 1,400% by 2022. Notably, 2020 marked a pivotal year for Supernus, with costs more than tripling compared to the previous year. These insights highlight the dynamic nature of cost management in the pharmaceutical sector, emphasizing the need for companies to adapt to market demands and operational challenges.
Eli Lilly and Company vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Sanofi vs Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Pharming Group N.V.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Pharming Group N.V.
Analyzing Cost of Revenue: Catalent, Inc. and Pharming Group N.V.
Catalent, Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Exelixis, Inc. vs Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue: Key Insights for Veracyte, Inc. and Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.'s Expenses